한글목차

심장 워크스테이션 세계 시장은 2024년에는 3억 6,521만 달러로 평가되었으며, 2030년에는 6억 1,775만 달러에 달할 것으로 예측되며, 예측 기간 동안 CAGR 9.13%로 성장할 것으로 예측됩니다.

시장 성장의 원동력은 심혈관질환(CVDs)의 발병률 증가와 조기 발견 및 정확한 진단에 대한 중요성 증가에 기인합니다. 심장 워크스테이션은 심전도, 심초음파, 심장 CT, MRI 등 다양한 심장 영상 촬영 기법의 데이터를 중앙 집중식 플랫폼에 통합함으로써 임상 환경에서 매우 중요한 역할을 하고 있습니다. 이러한 시스템은 진단 정확도를 높이고, 임상 워크플로우를 간소화하며, 정보에 입각한 의사결정을 지원함으로써 궁극적으로 환자 치료를 개선할 수 있습니다.

인구 고령화와 고혈압, 당뇨병, 비만과 같은 생활습관 관련 건강 위험의 증가로 인해 세계 수요는 더욱 증가하고 있습니다. 심혈관질환은 여전히 전 세계 사망 원인 1위이기 때문에 의료 시스템은 첨단 진단 기술에 투자하고 있습니다. 심장 워크스테이션 또한 AI, 머신러닝, 분석의 통합을 통해 이미지 판독을 개선하고 일상적인 프로세스를 자동화하기 위해 진화하고 있으며, PACS, HIS, EHR 플랫폼과의 상호운용성뿐만 아니라 클라우드 지원 및 원격 액세스 솔루션에 대한 관심도 높아지고 있습니다. 클라우드 지원 솔루션과 원격 액세스 솔루션에 대한 관심이 높아지고 있으며, 보다 확장 가능하고 협진적인 의료를 가능하게 하고 있습니다. 시각화 기능을 강화하고 진단 소요 시간을 단축한 사용자 친화적인 시스템에 대한 요구가 높아지면서 시장 보급이 더욱 가속화되고 있습니다.

주요 시장 촉진요인

심혈관질환(CVDs) 부담 증가

주요 시장 과제

높은 도입 및 유지보수 비용

주요 시장 동향

멀티모달리티 이미징 플랫폼에 대한 수요 증가

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 심장 워크스테이션 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 최종 용도별(병원, 외래 수술 센터, 의사 진료소/전문 클리닉/오피스 기반 연구실, 숙련 간호 시설, 기타)
  • 유통 채널별(의료 서지 유통, IT/CDW/VAR(부가가치 재판업체))
  • 기업별(2024)
  • 지역별
• 시장 맵

제6장 북미의 심장 워크스테이션 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 심장 워크스테이션 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 심장 워크스테이션 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 심장 워크스테이션 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 심장 워크스테이션 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 혼란 : 분쟁, 팬데믹, 무역장벽

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Medtronic plc
• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.
• Baxter International Inc.
• AFC Industries, Inc.
• SCHILLER AG
• EDAN Instruments, Inc.
• CONTEC Medical Systems Co., Ltd.
• Lepu Medical Technology(Beijing) Co., Ltd.
• Cardioline S.p.A.

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

영문목차

The Global Cardiac Workstation Market was valued at USD 365.21 million in 2024 and is projected to reach USD 617.75 million by 2030, growing at a CAGR of 9.13% during the forecast period. Market growth is being fueled by the rising incidence of cardiovascular diseases (CVDs) and growing emphasis on early detection and accurate diagnostics. Cardiac workstations have become crucial in clinical environments by integrating data from various cardiac imaging modalities-such as ECG, echocardiography, cardiac CT, and MRI-into a centralized platform. These systems enhance diagnostic accuracy, streamline clinical workflows, and support informed decision-making, ultimately improving patient care.

The global demand is further driven by aging populations and increasing lifestyle-related health risks like hypertension, diabetes, and obesity. As cardiovascular diseases remain the leading cause of death worldwide, healthcare systems are investing in advanced diagnostic technologies. Cardiac workstations are also evolving through the integration of AI, machine learning, and analytics to improve imaging interpretation and automate routine processes. Interoperability with PACS, HIS, and EHR platforms, along with rising interest in cloud-enabled and remote-access solutions, is enabling more scalable and collaborative care. The growing need for user-friendly systems with enhanced visualization capabilities and faster diagnostic turnaround times is further accelerating market adoption.

Key Market Drivers

Increasing Burden of Cardiovascular Diseases (CVDs)

The global surge in cardiovascular diseases is a major force driving the demand for cardiac workstations. In the U.S. alone, heart disease accounted for nearly 703,000 deaths in 2022, or approximately 20% of all deaths. This alarming trend has amplified the need for sophisticated diagnostic platforms that integrate imaging data from ECG, CT, MRI, and angiography to support comprehensive cardiac assessments. Cardiac workstations offer healthcare professionals a consolidated view of a patient's cardiovascular status, enabling faster diagnosis and more personalized treatment.

As healthcare facilities face rising volumes of patients undergoing stress testing, outpatient screening, and chronic disease monitoring, investment in advanced diagnostic systems is becoming a clinical priority. These workstations support streamlined workflows, multidisciplinary collaboration, and improved reporting consistency. The movement toward early-stage detection and non-invasive diagnostics further reinforces adoption. National screening programs and value-based care initiatives are also bolstering demand for cardiac workstations as tools that enhance care quality while meeting regulatory benchmarks.

Key Market Challenges

High Cost of Implementation and Maintenance

One of the primary obstacles to widespread adoption of cardiac workstations is the high cost associated with procurement and long-term maintenance. These systems often require significant capital investment, particularly those equipped with multi-modality integration, AI capabilities, and cloud access. For many healthcare providers, especially in emerging markets or budget-constrained environments, the financial burden is a major deterrent.

Beyond the initial purchase price, implementing a cardiac workstation typically involves upgrades to IT infrastructure, secure data storage capabilities, and system integration with EHRs and HIS platforms. These processes demand specialized technical expertise and can incur further costs through consultation, customization, and training. Additionally, maintaining system performance over time involves ongoing service contracts, software updates, and cybersecurity enhancements, all of which contribute to the total cost of ownership. As a result, cost-efficiency remains a central concern for providers evaluating these technologies.

Key Market Trends

Growing Demand for Multi-Modality Imaging Platforms

A key trend shaping the cardiac workstation market is the increasing preference for platforms that integrate multiple imaging modalities. Given the complexity of cardiovascular conditions, clinicians require solutions that provide comprehensive views by combining data from ECG, echocardiography, CT, MRI, and nuclear cardiology. Multi-modality platforms allow clinicians to analyze diverse datasets from a single interface, improving diagnostic accuracy and workflow efficiency.

This unified approach eliminates the need for toggling between disparate systems, thus reducing errors, shortening diagnostic timelines, and improving collaboration across departments. These systems also support advanced visualization and reporting tools, facilitating detailed assessments that guide treatment planning. As the clinical landscape evolves, hospitals and diagnostic centers are prioritizing investments in integrated imaging platforms that enhance decision-making and support personalized care strategies.

Key Market Players

• Medtronic plc
• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.
• Baxter International Inc.
• AFC Industries, Inc.
• SCHILLER AG
• EDAN Instruments, Inc.
• CONTEC Medical Systems Co., Ltd.
• Lepu Medical Technology (Beijing) Co., Ltd.
• Cardioline S.p.A.

Report Scope:

In this report, the Global Cardiac Workstation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiac Workstation Market, By End-use:

• Hospitals
• Ambulatory Surgical Centers
• Physician Offices/ Specialty Clinics/ Office Based Labs
• Skilled Nursing Facilities
• Others

Cardiac Workstation Market, By Distribution Channel:

• Medical Surge Distribution
• IT/ CDW/ VAR-Value Added Reseller

Cardiac Workstation Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiac Workstation Market.

Available Customizations:

Global Cardiac Workstation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Cardiac Workstation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By End-use (Hospitals, Ambulatory Surgical Centers, Physician Offices/ Specialty Clinics/ Office Based Labs, Skilled Nursing Facilities, Others)
  • 5.2.2. By Distribution Channel (Medical Surge Distribution, IT/ CDW/ VAR-Value Added Reseller)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Cardiac Workstation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By End-use
  • 6.2.2. By Distribution Channel
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cardiac Workstation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By End-use
      • 6.3.1.2.2. By Distribution Channel
  • 6.3.2. Mexico Cardiac Workstation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By End-use
      • 6.3.2.2.2. By Distribution Channel
  • 6.3.3. Canada Cardiac Workstation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By End-use
      • 6.3.3.2.2. By Distribution Channel

7. Europe Cardiac Workstation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By End-use
  • 7.2.2. By Distribution Channel
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cardiac Workstation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By End-use
      • 7.3.1.2.2. By Distribution Channel
  • 7.3.2. Germany Cardiac Workstation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By End-use
      • 7.3.2.2.2. By Distribution Channel
  • 7.3.3. United Kingdom Cardiac Workstation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By End-use
      • 7.3.3.2.2. By Distribution Channel
  • 7.3.4. Italy Cardiac Workstation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By End-use
      • 7.3.4.2.2. By Distribution Channel
  • 7.3.5. Spain Cardiac Workstation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By End-use
      • 7.3.5.2.2. By Distribution Channel

8. Asia-Pacific Cardiac Workstation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By End-use
  • 8.2.2. By Distribution Channel
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cardiac Workstation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By End-use
      • 8.3.1.2.2. By Distribution Channel
  • 8.3.2. India Cardiac Workstation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By End-use
      • 8.3.2.2.2. By Distribution Channel
  • 8.3.3. South Korea Cardiac Workstation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By End-use
      • 8.3.3.2.2. By Distribution Channel
  • 8.3.4. Japan Cardiac Workstation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By End-use
      • 8.3.4.2.2. By Distribution Channel
  • 8.3.5. Australia Cardiac Workstation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By End-use
      • 8.3.5.2.2. By Distribution Channel

9. South America Cardiac Workstation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By End-use
  • 9.2.2. By Distribution Channel
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cardiac Workstation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By End-use
      • 9.3.1.2.2. By Distribution Channel
  • 9.3.2. Argentina Cardiac Workstation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By End-use
      • 9.3.2.2.2. By Distribution Channel
  • 9.3.3. Colombia Cardiac Workstation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By End-use
      • 9.3.3.2.2. By Distribution Channel

10. Middle East and Africa Cardiac Workstation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By End-use
  • 10.2.2. By Distribution Channel
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cardiac Workstation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By End-use
      • 10.3.1.2.2. By Distribution Channel
  • 10.3.2. Saudi Arabia Cardiac Workstation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By End-use
      • 10.3.2.2.2. By Distribution Channel
  • 10.3.3. UAE Cardiac Workstation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By End-use
      • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Koninklijke Philips N.V.
• 15.3. GE HealthCare Technologies Inc.
• 15.4. Baxter International Inc.
• 15.5. AFC Industries, Inc.
• 15.6. SCHILLER AG
• 15.7. EDAN Instruments, Inc.
• 15.8. CONTEC Medical Systems Co., Ltd.
• 15.9. Lepu Medical Technology (Beijing) Co., Ltd.
• 15.10. Cardioline S.p.A.

16. Strategic Recommendations

17. About Us & Disclaimer